JPRN-UMIN000031890已完成3 期
Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty - Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Inability to communicate lucidly 2.Bilateral TKA 3.revision knee arthroplasty 4.Under 20 years old 5.Allergy to any of the drugs used in this study 6.ASA-PS > III 7.Chronic opioid use 8.Diabetes mellitus with sensory disorders 9.Neurological disability 10.Infections around femoral crease 11.Platelet < 5.0 * 10^4 /mcl 12.Pregnancy, possibility of pregnancy, or breast-feeding women 13.Contraindications to peripheral nerve blocks
研究者
相似试验
进行中（未招募）
不适用
A double-masked randomized cross-over study comparing the effect of Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol) fixed combination on intraocular pressure and ocular blood flow in patients with primary open angle glaucoma or ocular hypertensioGlaucomaEUCTR2005-004060-24-ATDepartment of Clinical Pharmacology
已完成
4 期
Randomized double-masked comparative study of intraocular pressure and wound status between eyes immediately after scleral tunnel incision and clear corneal incision cataract surgeryCataractJPRN-UMIN000013526Hayashi Eye Hospital64
进行中（未招募）
不适用
A double-masked, randomized, parallel-group study to investigate the pharmacodynamics, safety, and systemic pharmacokinetics of pazopanib eye drops, administered for 28 days to adult subjects with choroidal neovascular age-related macular degeneration. - Pazopanib eye drops in neovascular AMDeovascular age-related macular degenerationMedDRA version: 9.1Level: LLTClassification code 10025409Term: Macular degenerationEUCTR2007-006073-84-ITGlaxoSmithKline Research and Development45
进行中（未招募）
不适用
A double-masked, randomized, parallel-group study to investigate the pharmacodynamics, safety, and systemic pharmacokinetics of pazopanib eye drops, administered for 28 days to adult subjects with neovascular age-related maculardegeneratioeovascular age-related macular degenerationMedDRA version: 9.1Level: LLTClassification code 10025409Term: Macular degenerationEUCTR2007-006073-84-BEGlaxoSmithKiline Research and Development75
进行中（未招募）
1 期
Study to evaluate the efficacy, safety, tolerability and the extent to which the study drug is distributed in the body of multiple doses of QR-110 in subjects with LCA10 compared to a sham procedure. The study will be double-masked, randomized and controlled which means that both patients and study staff will not know and cannot influence who receives which treatment (study drug of sham).eber's Congenital Amaurosis (LCA) due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 GeneMedDRA version: 20.0Level: PTClassification code 10070667Term: Leber's congenital amaurosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-003501-25-ITPROQR THERAPEUTICS N.V.30